Search bioRxiv⌕ Search

Biology subjects

ROYER, G.

Publications and source records attributed to ROYER, G..

2 recordsLinked to original sources

Identification of specific metabolic capacities associated with major extraintestinal pathogenic Escherichia coli lineages

Bacterial niche colonization relies on multiple factors, among which the metabolic capacity to utilize specific substrates is pivotal, especially within complex microbiota where nutrient competition is intense. Escherichia coli, a gut commensal of humans and vertebrates, is also an opportunistic pathogen responsible for both intestinal and extraintestinal infections, including bloodstream infections (BSI). To identify metabolic specificities of pathogenic strains that could explain the emergence and success of major clones, we leveraged a well-characterized dataset of 1,498 genomes from both commensal and extraintestinal pathogenic epidemiologically relevant French isolates. Using a pangenomic framework, we conducted a large-scale analysis of metabolic pathways. Although metabolism was far more conserved than gene content, we found substantial metabolic diversity across the species, with over 50% of pathways being variable, mainly involving biosynthetic and degradation processes. Phylogeny had a major impact on metabolic profiles, while no specific pathway was associated with lifestyle (commensal vs. pathogenic) or BSI portal of entry. However, we identified clone-specific metabolic capacities. For example, pathways involved in 5-deoxynucleoside recycling were enriched in the major extraintestinal pathogen (ExPEC) clone STc69. In phylogroup B2, several clone-specific pathways enabled degradation of plant-derived compounds. Notably, detailed analysis of the D-apiose degradation revealed a functional pathway strongly associated with the STc131 and STc14 pandemic clones. Overall, our study highlights multiple lineage-specific metabolic capacities that may contribute to the ecological success and dissemination of most prevalent ExPEC clones. ImportanceAccording to the nutrient-niche hypothesis, both commensal and pathogenic E. coli strains must exploit distinct substrates to grow and persist in their primary habitat alongside resident microbiota. Such niche differentiation also occurs between E. coli populations competing within the same environment and partly explains the stable coexistence of strains in the gut. With this in mind, we search for specific associations between metabolic pathways and strain origin. However, metabolic profiles were predominantly shaped by phylogeny, reflecting the species clonal structure and the close link between phylogenetic background and lifestyle. Among the lineage-specific determinants, we identified several pathways associated with worldwide spread clones responsible for bloodstream infections, supporting the existence of clone-specific strategies for niche adaptation.

genomics↗

Chlorhexidine reduced susceptibility associated to tetracycline resistance in clinical isolates of Escherichia coli

Chlorhexidine is a widely used antiseptic in hospital and community healthcare. Decreased susceptibility to this compound has been recently described in Klebsiella pneumoniae and Pseudomonas aeruginosa, together with cross-resistance to colistin. Surprisingly, few data are available for Escherichia coli, the main species responsible for community and healthcare-associated infections. In order to decipher chlorhexidine resistance mechanisms in E. coli, we studied both in vitro derived and clinical isolates through whole-genome sequence analysis. Comparison of strains grown in vitro under chlorhexidine pressure identified mutations in the gene mlaA coding for a phospholipid transport system. Phenotypic analyses of single-gene mutant from the Keio collection confirmed the role of this mutation in the decreased susceptibility to chlorhexidine. However, mutations in mlaA were not found in isolates from large clinical collections. In contrast, genome wide association studies (GWAS) showed that, in clinical strains, chlorhexidine reduced susceptibility was associated with the presence of tetA genes of class B coding for efflux pumps and located in a Tn10 transposon. Construction of recombinant strains in E. coli K-12 confirmed the role of tetA determinant in acquired resistance to both chlorhexidine and tetracycline. Our results reveal two different evolutionary paths leading to chlorhexidine decreased susceptibility: one restricted to in vitro evolution conditions and involving a retrograde phospholipid transport system; the other observed in clinical isolates associated with efflux pump TetA. None of these mechanisms provides cross-resistance to colistin or to the cationic surfactant octenidine. This work demonstrates the GWAS power to identify new resistance mechanisms in bacterial species.

microbiology↗